$80m

Stablecoin payments startup KAST raised an $80M Series A; sources say the raise is at a $600M valuation and KAST expects a $100M annual revenue run rate in 2026

Stablecoin payments startup KAST raised an $80M Series A; sources say the raise is at a $600M valuation and KAST expects a $100M annual revenue run rate in 2026

KAST, a stablecoin payments firm, has raised $80 million in its latest funding round, as venture capitalists continue to pour money …

Nominal, which makes software for the defense, space, energy, and automotive sectors, raised an $80M Series B extension led by Founders Fund at a $1B valuation

Nominal, which makes software for the defense, space, energy, and automotive sectors, raised an $80M Series B extension led by Founders Fund at a $1B valuation

Salt Lake City-based Jump, a provider of AI tools for financial advisors to automate meeting prep and more, raised an $80M Series B led by Insight Partners

Jump, a Salt Lake City, UT-based provider of artificial intelligence (AI) solutions for financial advisors and other financial services providers …

Braintrust, which helps companies evaluate and monitor their AI tools' performance, raised an $80M Series B led by Iconiq at an $800M post-money valuation

Braintrust, which helps companies evaluate and monitor their AI tools' performance, raised an $80M Series B led by Iconiq at an $800M post-money valuation

Braintrust, a startup building AI observability and evaluation tools, raised an $80 million Series B led by Iconiq …

AI video startup Higgsfield raised an $80M Series A extension from Accel and others at a $1.3B+ valuation, and says it hit a $200M annualized revenue run rate

AI video startup Higgsfield raised an $80M Series A extension from Accel and others at a $1.3B+ valuation, and says it hit a $200M annualized revenue run rate

NYC-based Proxima, which uses AI to design drugs that control protein interactions, raised an $80M seed led by DCVC; Nvidia, Roivant, and Braidwell invested too

Proxima, a biotech startup using artificial intelligence to design drugs that control protein interactions, raised $80 million in seed funding …